ClinVar Miner

Submissions for variant NM_000249.4(MLH1):c.1853A>C (p.Lys618Thr)

dbSNP: rs63750449
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 22
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000075384 SCV000106379 no known pathogenicity Lynch syndrome 2013-09-05 reviewed by expert panel research Multifactorial likelihood analysis posterior probability <0.001
Ambry Genetics RCV000132375 SCV000187465 benign Hereditary cancer-predisposing syndrome 2014-11-18 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Eurofins Ntd Llc (ga) RCV000174993 SCV000226409 likely benign not specified 2014-09-24 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000132375 SCV000537392 benign Hereditary cancer-predisposing syndrome 2022-01-01 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000174993 SCV000539634 benign not specified 2020-08-10 criteria provided, single submitter clinical testing The p.Lys618Thr variant in MLH1 is classified as benign because it has been identified in 0.57% (735/129116, 2 homozygotes) chromosomes by gnomAD (http://gnomad.broadinstitute.org) and is a common haplotype with c.1852A>G. ACMG/AMP Criteria applied: BA1.
Genetic Services Laboratory, University of Chicago RCV000174993 SCV000595804 likely benign not specified 2017-04-03 criteria provided, single submitter clinical testing
Invitae RCV001080445 SCV000751221 benign Hereditary nonpolyposis colorectal neoplasms 2024-01-18 criteria provided, single submitter clinical testing
Mendelics RCV000615824 SCV001136426 benign Colorectal cancer, hereditary nonpolyposis, type 2 2019-05-28 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000615824 SCV001305811 uncertain significance Colorectal cancer, hereditary nonpolyposis, type 2 2019-06-10 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000174993 SCV001470327 benign not specified 2019-11-12 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000114853 SCV001748066 likely benign not provided 2023-08-01 criteria provided, single submitter clinical testing MLH1: PP3, BS2
Sema4, Sema4 RCV000132375 SCV002528688 benign Hereditary cancer-predisposing syndrome 2020-05-10 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000174993 SCV002550417 benign not specified 2023-08-15 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002498362 SCV002809640 likely benign Mismatch repair cancer syndrome 1; Muir-Torré syndrome; Colorectal cancer, hereditary nonpolyposis, type 2 2022-04-21 criteria provided, single submitter clinical testing
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C. RCV000132375 SCV002819230 benign Hereditary cancer-predisposing syndrome 2022-11-22 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV003149735 SCV003838214 likely benign Breast and/or ovarian cancer 2023-06-22 criteria provided, single submitter clinical testing
Harris Lab, University of Minnesota RCV000114853 SCV000148748 not provided not provided no assertion provided not provided
Pathway Genomics RCV000144601 SCV000189928 likely benign Lynch syndrome 1 2014-07-24 no assertion criteria provided clinical testing
CSER _CC_NCGL, University of Washington RCV000148619 SCV000190334 uncertain significance Colorectal cancer, non-polyposis 2014-06-01 no assertion criteria provided research
Mayo Clinic Laboratories, Mayo Clinic RCV000174993 SCV000257071 uncertain significance not specified no assertion criteria provided research
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000114853 SCV000592425 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000174993 SCV001970435 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.